For five years, the clinical-stage pharmaceutical company has developed Enbumyst, a nasal spray intended to remove excess ...

Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.

The FDA has expanded the approval of Valtoco (diazepam nasal spray) to include treatment of seizure clusters in patients aged 2 to 5 years.

Nasal decongestant sprays are a popular remedy for relieving nasal congestion caused by colds, allergies and sinus infections ...

An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high tolerability and a very fast onset of action. This study assessed the pharmacokinetics and ...

ARS Pharmaceuticals has a recently launched needle-free epinephrine product for allergic reactions, neffy. See why I rate ...

A pharmacist has issued a warning over using nasal spray products when you've got a blocked or stuffy nose. Decongestant nasal sprays are medications designed to provide temporary relief from ...

“While hay fever has no cure, there are many ways you can help to relieve and manage symptoms. Your local pharmacist is ...

The recommended dose of Atzumi is 5.2mg, the contents of 1 nasal device, administered into 1 nostril. The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine) nasal ...

Previously called STS101, the company said Wednesday that the drug’s brand name is Atzumi and is indicated for acute migraine ...